Home › Asset managers › Compare 2024-2025 › Equitable vs Jackson National
Equitable 2024-2025 · Jackson National 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 11,158 | 8,823 | 328 | 2,007 | 96.4% | 90.3% |
| Board proposals | 8,777 | 6,964 | 308 | 1,505 | 95.8% | 89.9% |
| E&S shareholder proposals | 245 | 106 | 1 | 138 | 99.1% | 84.0% |
| Other items | 2,136 | 1,753 | 19 | 364 | 98.9% | 92.7% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
328 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Equitable | Jackson National |
|---|---|---|---|---|---|---|
| TERRITORIAL BANCORP INC. | November 6, 2024 | To approve and adopt the Agreement and Plan of Merger, dated as of April 26, 2024 (the "Merger Agreement"), by and between Hope Bancorp, Inc. ("Hope") and Territorial Bancorp Inc. ("Territorial"), and to approve the transactions contemplated by the Merger Agreement, including the merger (the "Merger") of Territorial with and into Hope (collectively, the "Merger Proposal"); Extraordinary Transactions |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| THE TIMKEN COMPANY | May 2, 2025 | Approval, on an advisory basis, of our named executive officer compensation. Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 7 funds |
| TRANSACT TECHNOLOGIES INC. | May 29, 2025 | Approval, on a non-binding, advisory basis, of the compensation of our named executive officers. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| TRAVELZOO | June 4, 2025 | Vote, on an advisory basis, to approve executive compensation. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| TREACE MEDICAL CONCEPTS INC. | May 20, 2025 | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 1 fund |
| TREDEGAR CORP. | May 8, 2025 | Non-Binding Advisory Vote to Approve Named Executive Officer Compensation Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 2 funds |
| TRUEBLUE INC. | May 14, 2025 | To approve, by advisory vote, compensation for our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| TRUECAR INC. | May 22, 2025 | Advisory vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| ULTRAGENYX PHARMACEUTICAL INC. | May 15, 2025 | Approval of the Second Amended and Restated 2023 Incentive Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 4 funds |
| ULTRALIFE CORP. | July 16, 2024 | To approve the adoption of the Ultralife Corporation 2024 Long-Term Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| UNISYS CORP. | May 8, 2025 | Advisory vote to approve executive compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| UNIVERSAL ELECTRONICS INC. | May 27, 2025 | Approval, on an advisory basis, of the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| UNIVERSAL HEALTH REALTY INCOME TRUST | June 11, 2025 | Advisory (nonbinding) vote to approve named executive officer compensation. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| USIO INC. | June 10, 2025 | To approve, on an advisory basis, the compensation paid to our Named Executive Officers for the year ended December 31, 2024. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| UTZ BRANDS INC. | April 24, 2025 | Non-binding, advisory vote to approve executive compensation Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| VANDA PHARMACEUTICALS INC. | June 5, 2025 | To approve, on an advisory basis, the Company's named executive officer compensation. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| VENTYX BIOSCIENCES INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| VERA BRADLEY INC. | June 5, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| VERACYTE INC. | June 17, 2025 | The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| VERVE THERAPEUTICS INC. | June 5, 2025 | Approval, on an advisory basis, of the compensation paid to our named executive officers. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 1 fund |
| VIKING HOLDINGS LTD | May 15, 2025 | Election of Director: Jack Weingart Director Elections |
Board | For | AGAINST 1 fund |
FOR 2 funds |
| VIMEO INC. | June 9, 2025 | Approve a non-binding advisory resolution to approve the compensation of the Company's named executive officers (say on pay). Say-on-Pay |
Board | For | FOR 6 funds |
AGAINST 2 funds |
| VOXX INTERNATIONAL CORP. | March 31, 2025 | To approve by a non-binding, advisory vote certain compensation arrangements for the Company's named executive officers in connection with the Merger. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 2 funds |
| VOYAGER THERAPEUTICS INC. | June 3, 2025 | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers. Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 1 fund |
| W&T OFFSHORE INC. | June 3, 2025 | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement pursuant to Item 402 of Regulation S-K. Say-on-Pay |
Board | For | FOR 7 funds |
AGAINST 2 funds |
| WESTWOOD H | April 30, 2025 | To approve the Eleventh Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan. Compensation |
Board | Not determined | FOR 1 fund |
AGAINST 2 funds |
| WHITEHAWK THERAPEUTICS INC. | June 11, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| XENIA HOTELS & RESORTS INC. | May 13, 2025 | To approve an amendment to the 2015 Incentive Award Plan to increase the number of shares that may be issued thereunder. Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
← Previous Page 4 of 4
How items are matched and positions counted: see the comparison table and the methodology. Built November 1, 2026 from SEC Form N-PX filings.